Citation Impact

Citing Papers

Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance
2007
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Linking class-switch recombination with somatic hypermutation
2001 StandoutNobel
Intraepithelial T cells and tumor proliferation
2009
Bioluminescent imaging of Cdk2 inhibition in vivo
2004 StandoutNobel
Virus replication begins in dendritic cells during the transmission of HIV-1 from mature dendritic cells to T cells
1999 StandoutNobel
CD34+ Cord Blood Cell-Transplanted Rag2−/− γc−/− Mice as a Model for Epstein-Barr Virus Infection
2008
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors
2007
Coexpression of BMI-1 and EZH2 Polycomb Group Genes in Reed-Sternberg Cells of Hodgkin’s Disease
2000
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit
2006 StandoutNobel
Deregulated degradation of the cdk inhibitor p27 and malignant transformation
2002
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Somatic insertions and deletions shape the human antibody repertoire 1 1Edited by J. Karn
1999 StandoutNobel
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
2016
Role of AID in Tumorigenesis
2007 StandoutNobel
AI in health and medicine
2022 Standout
Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders
2002
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Loss of the cell cycle inhibitors p21Cip1 and p27Kip1 enhances tumorigenesis in knockout mouse models
2002
Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations
2006
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
2002 Standout
RB and cell cycle progression
2006 Standout
Role of cell‐cycle regulators in lung cancer
2005
Genetic Alterations of the Retinoblastoma-Related Gene RB2/p130 Identify Different Pathogenetic Mechanisms in and among Burkitt's Lymphoma Subtypes
2000
Epstein-Barr virus: exploiting the immune system
2001 Standout
Preparing Medical Imaging Data for Machine Learning
2020 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma
2003
Bioluminescent Imaging of Ubiquitin Ligase Activity: Measuring Cdk2 Activity In Vivo Through Changes in p27 Turnover
2005 StandoutNobel
The polycomb group protein EZH2 is involved in progression of prostate cancer
2002 StandoutNature
Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
2004
Epstein–Barr virus: 40 years on
2004 Standout
Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma
1999
In Vivo Identification of Langerhans and Related Dendritic Cells Infected with HIV-1 Subtype E in Vaginal Mucosa of Asymptomatic Patients
2001 StandoutNobel
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
2009
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Cellular Origin of Human B-Cell Lymphomas
1999
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The ubiquitin system: pathogenesis of human diseases and drug targeting
2004 StandoutNobel
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex
2004 StandoutNatureNobel
CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair
1996
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL
2004
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
1999 StandoutNobel
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
2008
In Vivo Analysis of Aicda Gene Regulation: A Critical Balance between Upstream Enhancers and Intronic Silencers Governs Appropriate Expression
2013 StandoutNobel
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
The occurrence and significance of V gene mutations in B cell—Derived human malignancy
2001
Proceedings of the First International Conference on PEP005
2007
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Multiple Functions of Jab1 Are Required for Early Embryonic Development and Growth Potential in Mice
2004 StandoutNobel
Down-regulation of p27 by Two Mechanisms, Ubiquitin-mediated Degradation and Proteolytic Processing
1999
Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme
2000 StandoutNobel
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
1999
Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
2010 StandoutNobel
Impact of Third-Generation Drugs on the Activity of First-Line Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Meta-Analytical Approach
2009
Identification of Virus-Encoded MicroRNAs
2004 StandoutScience
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
1997
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation
2011 StandoutNobel
Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription
2000
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
2002 StandoutNobel
TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation
1999 StandoutNobel
Complex layers of genetic alteration in the generation of antibody diversity
2001 StandoutNobel
Diffuse large cell lymphoma
2011
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
2009 StandoutNobel
Multilocular peritoneal inclusion cysts (So-called cystic mesotheliomas)
1989
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
2008 Standout
Euphorbia Diterpenes: Isolation, Structure, Biological Activity, and Synthesis (2008–2012)
2014 Standout
Anaplastic lymphoma kinase: signalling in development and disease
2009
Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas
2003 StandoutNobel
Variable deletion and duplication at recombination junction ends: Implication for staggered double-strand cleavage in class-switch recombination
2001 StandoutNobel
Evidence for a Large Compartment of IgM-Expressing Memory B Cells in Humans
1997
Frequent occurrence of deletions and duplications during somatic hypermutation: Implications for oncogene translocations and heavy chain disease
1998
Platinum-Based Versus Non-Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of the Published Literature
2005

Works of Jun‐ichi Tamaru being referenced

Hyperactivated STAT3 in ALK–positive diffuse large B-cell lymphoma with clathrin-ALK fusion
2008
Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma
2015
Combination chemotherapy with irinotecan and adriamycin for refractory and relapsed non-Hodgkin's lymphoma
2000
Diagnosis using deep-learning artificial intelligence based on the endocytoscopic observation of the esophagus
2018
Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast
2004
Role of p27Kip1 and Cyclin-Dependent Kinase 2 in the Proliferation of Non-Small Cell Lung Cancer
1998
Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
1995
Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes
1994
Phase I/II Study of the Rituximab-EPOCT Regimen in Combination with Granulocyte Colony-Stimulating Factor in Patients with Relapsed or Refractory Follicular Lymphoma Including Evaluation of Its Cardiotoxicity Using B-Type Natriuretic Peptide and Troponin T Levels
2005
A CYSTIC ADENOMATOID TUMOR OF THE UTERUS SIMULATING LYMPHANGIOMA GROSSLY
1985
Rankless by CCL
2026